Journal of Clinical Medicine Research, ISSN 1918-3003 print, 1918-3011 online, Open Access |
Article copyright, the authors; Journal compilation copyright, J Clin Med Res and Elmer Press Inc |
Journal website https://www.jocmr.org |
Original Article
Volume 16, Number 4, April 2024, pages 164-169
Significance of Hypoalbuminemia in the Development of Thromboembolic Complications in Severe Cases of SARS-CoV-2 Coronavirus Infection
Figures
Tables
Attribute | TECs group | TEC-free group | P-value |
---|---|---|---|
Me: median; TEC: thromboembolic complication. | |||
Number of patients, n (%) | 127 (100%) | 1,507 (100%) | - |
Average age, Me (Q1 - Q3) | 75 (62.5 - 82.0) | 58 (47.0 - 68.0) | < 0.001 |
Male patients, n (%) | 71 (55.9%) | 776 (51.49%) | 0.339 |
Arterial hypertension, n (%) | 113 (88.97%) | 884 (58.65%) | < 0.001 |
Ischemic heart disease, n (%) | 116 (91.33%) | 447 (29.66%) | < 0.001 |
Chronic heart failure, n (%) | 53 (41.73%) | 148 (9.82%) | < 0.001 |
Chronic kidney disease, n (%) | 105 (82.67%) | 981 (65.09%) | < 0.001 |
Type 2 diabetes mellitus, n (%) | 54 (42.51%) | 238 (15.79%) | < 0.001 |
Obesity, n (%) | 23 (18.11%) | 175 (11.61%) | 0.031 |
Average pulmonary involvement, Me (Q1 - Q3) | 55% (37.5 - 67.5) | 37.5% (25.0 - 47.5) | < 0.001 |
Oxygen saturation on room air (SpO2), Me (Q1 - Q3) | 92.0% (88.0 - 95.0) | 95.0% (93.0 - 97.0) | < 0.001 |
Indicator | TECs group | TEC-free group | P-value |
---|---|---|---|
IL-6: interleukin-6; TEC: thromboembolic complication. | |||
C-reactive protein, mg/L | 129 (60.1 - 211) | 41.0 (12.2 - 97.6) | < 0.001 |
Ferritin, µg/L | 363 (207 - 516) | 314 (186 - 516) | 0.481 |
IL-6, pg/mL | 176 (52.9 - 471) | 39.4 (11.0 - 107) | < 0.001 |
Fibrinogen, g/L | 6.95 (4.98 - 9.13) | 5.70 (4.98 - 9.13) | 0.003 |